For Mary Long, the answer to her pain may, literally, be right around the corner.
The SMILE trial will seek to identify individuals at high risk for developing lupus and treat them before they ever transition into the disease.
The Scheinberg Award recognizes research excellence in the field of neurorehabiliation in MS.
New research will help physicians better identify blood relatives of lupus patients at risk for developing the disease.
The project is focused on lupus, which affects up to 1.5 million Americans.
OMRF’s Multiple Sclerosis Center turns five years old on March 15.